Copyright Reports & Markets. All rights reserved.

Global Animal Anti Rabies Vaccine Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Animal Anti Rabies Vaccine Product Introduction
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Animal Anti Rabies Vaccine Market Size Growth Rate by Type
      • 1.4.2 Vero Cell Rabies Vaccine
      • 1.4.3 Baby Hamster Kidney (BHK) Rabies Vaccine
      • 1.4.4 Chick Embryo Cell Rabies Vaccine
      • 1.4.5 Other
    • 1.5 Market by Application
      • 1.5.1 Global Animal Anti Rabies Vaccine Market Size Growth Rate by Application
      • 1.5.2 Pre-exposure Prophylaxis
      • 1.5.3 Post-exposure Prophylaxis
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Animal Anti Rabies Vaccine Market Size
      • 2.1.1 Global Animal Anti Rabies Vaccine Revenue 2014-2025
      • 2.1.2 Global Animal Anti Rabies Vaccine Sales 2014-2025
    • 2.2 Animal Anti Rabies Vaccine Growth Rate by Regions
      • 2.2.1 Global Animal Anti Rabies Vaccine Sales by Regions
      • 2.2.2 Global Animal Anti Rabies Vaccine Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Animal Anti Rabies Vaccine Sales by Manufacturers
      • 3.1.1 Animal Anti Rabies Vaccine Sales by Manufacturers
      • 3.1.2 Animal Anti Rabies Vaccine Sales Market Share by Manufacturers
    • 3.2 Animal Anti Rabies Vaccine Revenue by Manufacturers
      • 3.2.1 Animal Anti Rabies Vaccine Revenue by Manufacturers (2014-2019)
      • 3.2.2 Animal Anti Rabies Vaccine Revenue Share by Manufacturers (2014-2019)
    • 3.3 Animal Anti Rabies Vaccine Price by Manufacturers
    • 3.4 Animal Anti Rabies Vaccine Manufacturing Base Distribution, Product Types
      • 3.4.1 Animal Anti Rabies Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Animal Anti Rabies Vaccine Product Type
      • 3.4.3 Date of International Manufacturers Enter into Animal Anti Rabies Vaccine Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type

    • 4.1 Global Animal Anti Rabies Vaccine Sales by Type
    • 4.2 Global Animal Anti Rabies Vaccine Revenue by Type
    • 4.3 Animal Anti Rabies Vaccine Price by Type

    5 Breakdown Data by Application

    • 5.1 Overview
    • 5.2 Global Animal Anti Rabies Vaccine Breakdown Data by Application

    6 North America

    • 6.1 North America Animal Anti Rabies Vaccine by Country
      • 6.1.1 North America Animal Anti Rabies Vaccine Sales by Country
      • 6.1.2 North America Animal Anti Rabies Vaccine Revenue by Country
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Animal Anti Rabies Vaccine by Type
    • 6.3 North America Animal Anti Rabies Vaccine by Application

    7 Europe

    • 7.1 Europe Animal Anti Rabies Vaccine by Country
      • 7.1.1 Europe Animal Anti Rabies Vaccine Sales by Country
      • 7.1.2 Europe Animal Anti Rabies Vaccine Revenue by Country
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Animal Anti Rabies Vaccine by Type
    • 7.3 Europe Animal Anti Rabies Vaccine by Application

    8 Asia Pacific

    • 8.1 Asia Pacific Animal Anti Rabies Vaccine by Region
      • 8.1.1 Asia Pacific Animal Anti Rabies Vaccine Sales by Region
      • 8.1.2 Asia Pacific Animal Anti Rabies Vaccine Revenue by Region
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 South Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Thailand
      • 8.1.10 Malaysia
      • 8.1.11 Philippines
      • 8.1.12 Vietnam
    • 8.2 Asia Pacific Animal Anti Rabies Vaccine by Type
    • 8.3 Asia Pacific Animal Anti Rabies Vaccine by Application

    9 Central & South America

    • 9.1 Central & South America Animal Anti Rabies Vaccine by Country
      • 9.1.1 Central & South America Animal Anti Rabies Vaccine Sales by Country
      • 9.1.2 Central & South America Animal Anti Rabies Vaccine Revenue by Country
      • 9.1.3 Brazil
    • 9.2 Central & South America Animal Anti Rabies Vaccine by Type
    • 9.3 Central & South America Animal Anti Rabies Vaccine by Application

    10 Middle East and Africa

    • 10.1 Middle East and Africa Animal Anti Rabies Vaccine by Country
      • 10.1.1 Middle East and Africa Animal Anti Rabies Vaccine Sales by Country
      • 10.1.2 Middle East and Africa Animal Anti Rabies Vaccine Revenue by Country
      • 10.1.3 Turkey
      • 10.1.4 GCC Countries
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Animal Anti Rabies Vaccine by Type
    • 10.3 Middle East and Africa Animal Anti Rabies Vaccine by Application

    11 Company Profiles

    • 11.1 Sanofi
      • 11.1.1 Sanofi Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Sanofi Animal Anti Rabies Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Sanofi Animal Anti Rabies Vaccine Products Offered
      • 11.1.5 Sanofi Recent Development
    • 11.2 GSK
      • 11.2.1 GSK Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 GSK Animal Anti Rabies Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 GSK Animal Anti Rabies Vaccine Products Offered
      • 11.2.5 GSK Recent Development
    • 11.3 Merck
      • 11.3.1 Merck Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Merck Animal Anti Rabies Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Merck Animal Anti Rabies Vaccine Products Offered
      • 11.3.5 Merck Recent Development
    • 11.4 Yisheng Group
      • 11.4.1 Yisheng Group Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Yisheng Group Animal Anti Rabies Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Yisheng Group Animal Anti Rabies Vaccine Products Offered
      • 11.4.5 Yisheng Group Recent Development
    • 11.5 Serum Institute of India
      • 11.5.1 Serum Institute of India Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Serum Institute of India Animal Anti Rabies Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Serum Institute of India Animal Anti Rabies Vaccine Products Offered
      • 11.5.5 Serum Institute of India Recent Development
    • 11.6 Cadila Pharmaceuticals
      • 11.6.1 Cadila Pharmaceuticals Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Cadila Pharmaceuticals Animal Anti Rabies Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Cadila Pharmaceuticals Animal Anti Rabies Vaccine Products Offered
      • 11.6.5 Cadila Pharmaceuticals Recent Development
    • 11.7 Boehringer Ingelheim
      • 11.7.1 Boehringer Ingelheim Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Boehringer Ingelheim Animal Anti Rabies Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Boehringer Ingelheim Animal Anti Rabies Vaccine Products Offered
      • 11.7.5 Boehringer Ingelheim Recent Development
    • 11.8 Liaoning Chengda
      • 11.8.1 Liaoning Chengda Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Liaoning Chengda Animal Anti Rabies Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Liaoning Chengda Animal Anti Rabies Vaccine Products Offered
      • 11.8.5 Liaoning Chengda Recent Development

    12 Future Forecast

    • 12.1 Animal Anti Rabies Vaccine Market Forecast by Regions
      • 12.1.1 Global Animal Anti Rabies Vaccine Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Animal Anti Rabies Vaccine Revenue Forecast by Regions 2019-2025
    • 12.2 Animal Anti Rabies Vaccine Market Forecast by Type
      • 12.2.1 Global Animal Anti Rabies Vaccine Sales Forecast by Type 2019-2025
      • 12.2.2 Global Animal Anti Rabies Vaccine Revenue Forecast by Type 2019-2025
    • 12.3 Animal Anti Rabies Vaccine Market Forecast by Application
    • 12.4 North America Animal Anti Rabies Vaccine Forecast
    • 12.5 Europe Animal Anti Rabies Vaccine Forecast
    • 12.6 Asia Pacific Animal Anti Rabies Vaccine Forecast
    • 12.7 Central & South America Animal Anti Rabies Vaccine Forecast
    • 12.8 Middle East and Africa Animal Anti Rabies Vaccine Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Animal Anti Rabies Vaccine Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      This report studies the global market size of Animal Anti Rabies Vaccine in key regions like North America, Europe, China and Japan, focuses on the consumption of Animal Anti Rabies Vaccine in these regions.
      This research report categorizes the global Animal Anti Rabies Vaccine market by top players/brands, region, type and end user. This report also studies the global Animal Anti Rabies Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Sanofi
      GSK
      Merck
      Yisheng Group
      Serum Institute of India
      Cadila Pharmaceuticals
      Boehringer Ingelheim
      Liaoning Chengda

      Animal Anti Rabies Vaccine market size by Type
      Vero Cell Rabies Vaccine
      Baby Hamster Kidney (BHK) Rabies Vaccine
      Chick Embryo Cell Rabies Vaccine
      Other

      Animal Anti Rabies Vaccine market size by Applications
      Pre-exposure Prophylaxis
      Post-exposure Prophylaxis

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      Indonesia
      Thailand
      Malaysia
      Philippines
      Vietnam
      Central & South America
      Brazil
      Middle East & Africa
      Turkey
      GCC Countries
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Animal Anti Rabies Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Animal Anti Rabies Vaccine market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Animal Anti Rabies Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Animal Anti Rabies Vaccine submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Animal Anti Rabies Vaccine are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Animal Anti Rabies Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now